Dark | Light
# $ibb

Breaking News: Market experiences sharp downturn amid regulatory concerns. Community engagement surges as users seek clarity and support.

### About $ibb
This refers to the decentralized digital currency and its associated ecosystem.  

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ibb/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ibb/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Month: [-------] -53%  
[--] Months: [---------] +21%  
[--] Year: [---------] +17%  
1-Year High: [-------] on 2025-11-17  
1-Year Low: [-----] on 2025-09-20  

Engagements by network (24h):
X: [-----]
YouTube: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ibb/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ibb/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
1-Year High: [---] on 2025-11-20  
1-Year Low: [--] on 2025-12-06  

Mentions by network (24h):
X: [---]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ibb/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ibb/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $ibb in the last [--] hours which is down 3.60% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-11-20  
1-Year Low: [--] on 2025-09-14  

The most influential creators that mention $ibb in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BOSSTRADING0](/creator/twitter/BOSSTRADING0)       | [--]    | [-----]     | [--]    | [-----]       |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]     | [-----]       |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [-----]       |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]    | [-----]       |
| [@nixon786](/creator/twitter/nixon786)               | [--]    | [---]       | [--]    | [---]         |
| [@BRSreality](/creator/twitter/BRSreality)           | [--]    | [---]       | [--]     | [---]         |
| [@ej23ny](/creator/twitter/ej23ny)                   | [--]    | [-----]     | [--]     | [---]         |
| [@safehavenmoney](/creator/twitter/safehavenmoney)   | [--]    | [------]    | [--]     | [---]         |
| [@TheNorthStar5](/creator/twitter/TheNorthStar5)     | [--]    | [---]       | [--]     | [--]          |
| [@LTbioinvestor](/creator/twitter/LTbioinvestor)     | [--]   | [------]    | [--]     | [--]          |

[View More](/list/creators/$ibb/100)
  
  
### Sentiment: 77%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ibb/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ibb/time-series/sentiment.tsv)  
Current Value: 77%  
Daily Average: 86%  
[--] Month: 66% -20%  
[--] Months: 66% -28%  
[--] Year: 66% -27%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 54% on 2025-05-12  

Most Supportive Themes:
- Community Building: (60%) Focus on fostering a strong and engaged community through interactive content and discussions.
- Educational Content: (30%) Providing valuable information and insights related to the topic to empower the audience.
  
Most Critical Themes:
- Market Volatility: (85.5%) Significant fluctuations in the market are causing concern among investors and participants.
- Regulatory Uncertainty: (70.2%) Unclear or changing regulations are creating a challenging environment for growth and adoption.
  

### Top $ibb Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"🧬 Weekly & YTD Biotech Moves Week ending 01/30/26 $XBI: -2.57% ($124.75) 🔴 $IBB: -1.65% ($172.43) 🔴 Year-to-date $XBI: 2.31% 🟢 $IBB: 2.17% 🟢 🧬 Biotech Weekly News Largest single-day stock moves during the week ending 01/30/26 📈 $TRAW 15% Enrollment of Ratutrelvir Clinical Study $PLX 13% Positive CHMP Opinion for Elfabrio $LSTA 12% Termination License Agreement for Certepetide $ALXO 11% CD47 Expression Predicts https://t.co/LMFqG2dcY2 🧬 Biotech Weekly News Largest single-day stock moves during the week ending 01/30/26 📈 $TRAW 15% Enrollment of Ratutrelvir Clinical Study $PLX 13%"  
[X Link](https://x.com/BiopharmIQ/status/2017608115752239316) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-01-31T14:37Z 28.9K followers, [----] engagements


"$SPY $DIA $IWM $QQQ $IBB $XBI Ukraine USSR peace Iran Mehran Lebanon Zoghbi Pakistan OIC Muslim South Korea Philippines Asia France Germany Spain EU says harm Vaishnav patel due to race religion & religion symbol. Says harm to Vaishnav patel prospers USSR OIC Asia EU"  
[X Link](https://x.com/nixon786/status/2017596257372389470) [@nixon786](/creator/x/nixon786) 2026-01-31T13:50Z [---] followers, [---] engagements


"$MREO Alvelestat Chronic treatment of AATD disease etc early and late stage of #AATD Currently is the only small molecule advancing into phase [--] #AATD is very difficult to be cured specially #AATD lung disease by $BEAM $WVE $XBI $IBB $MREO its ridiculous that Alvelestat has $0 value despite good results in severe alpha-1 antitrypsin deficiency. #AATD [--] randomized controlled phase [--] trials [---] patients. -Favorable safety profile -good efficacy $WVE $Beam $prme $NTLA $XBI $MREO its ridiculous that Alvelestat has $0 value despite good results in severe alpha-1 antitrypsin deficiency. #AATD 2"  
[X Link](https://x.com/ej23ny/status/2017290481839882344) [@ej23ny](/creator/x/ej23ny) 2026-01-30T17:35Z [----] followers, [----] engagements


"$azn investing in #china not helping no (good) news no party #biotechs $XBI $IBB $BBC no (good) news no party #biotechs $XBI $IBB $BBC"  
[X Link](https://x.com/LTbioinvestor/status/2017268873360293889) [@LTbioinvestor](/creator/x/LTbioinvestor) 2026-01-30T16:09Z 17.2K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

$ibb

Breaking News: Market experiences sharp downturn amid regulatory concerns. Community engagement surges as users seek clarity and support.

About $ibb

This refers to the decentralized digital currency and its associated ecosystem.

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Month: [-------] -53%
[--] Months: [---------] +21%
[--] Year: [---------] +17%
1-Year High: [-------] on 2025-11-17
1-Year Low: [-----] on 2025-09-20

Engagements by network (24h): X: [-----] YouTube: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
1-Year High: [---] on 2025-11-20
1-Year Low: [--] on 2025-12-06

Mentions by network (24h): X: [---] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $ibb in the last [--] hours which is down 3.60% from [--] in the previous [--] hours Daily Average: [--]
1-Year High: [---] on 2025-11-20
1-Year Low: [--] on 2025-09-14

The most influential creators that mention $ibb in the last [--] hours

Creator Rank Followers Posts Engagements
@BOSSTRADING0 [--] [-----] [--] [-----]
@semodough [--] [------] [--] [-----]
@doepke_michel [--] [------] [--] [-----]
@NightOwlBiotech [--] [-----] [--] [-----]
@nixon786 [--] [---] [--] [---]
@BRSreality [--] [---] [--] [---]
@ej23ny [--] [-----] [--] [---]
@safehavenmoney [--] [------] [--] [---]
@TheNorthStar5 [--] [---] [--] [--]
@LTbioinvestor [--] [------] [--] [--]

View More

Sentiment: 77%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 77%
Daily Average: 86%
[--] Month: 66% -20%
[--] Months: 66% -28%
[--] Year: 66% -27%
1-Year High: 100% on 2025-02-15
1-Year Low: 54% on 2025-05-12

Most Supportive Themes:

  • Community Building: (60%) Focus on fostering a strong and engaged community through interactive content and discussions.
  • Educational Content: (30%) Providing valuable information and insights related to the topic to empower the audience.

Most Critical Themes:

  • Market Volatility: (85.5%) Significant fluctuations in the market are causing concern among investors and participants.
  • Regulatory Uncertainty: (70.2%) Unclear or changing regulations are creating a challenging environment for growth and adoption.

Top $ibb Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"🧬 Weekly & YTD Biotech Moves Week ending 01/30/26 $XBI: -2.57% ($124.75) 🔴 $IBB: -1.65% ($172.43) 🔴 Year-to-date $XBI: 2.31% 🟢 $IBB: 2.17% 🟢 🧬 Biotech Weekly News Largest single-day stock moves during the week ending 01/30/26 📈 $TRAW 15% Enrollment of Ratutrelvir Clinical Study $PLX 13% Positive CHMP Opinion for Elfabrio $LSTA 12% Termination License Agreement for Certepetide $ALXO 11% CD47 Expression Predicts https://t.co/LMFqG2dcY2 🧬 Biotech Weekly News Largest single-day stock moves during the week ending 01/30/26 📈 $TRAW 15% Enrollment of Ratutrelvir Clinical Study $PLX 13%"
X Link @BiopharmIQ 2026-01-31T14:37Z 28.9K followers, [----] engagements

"$SPY $DIA $IWM $QQQ $IBB $XBI Ukraine USSR peace Iran Mehran Lebanon Zoghbi Pakistan OIC Muslim South Korea Philippines Asia France Germany Spain EU says harm Vaishnav patel due to race religion & religion symbol. Says harm to Vaishnav patel prospers USSR OIC Asia EU"
X Link @nixon786 2026-01-31T13:50Z [---] followers, [---] engagements

"$MREO Alvelestat Chronic treatment of AATD disease etc early and late stage of #AATD Currently is the only small molecule advancing into phase [--] #AATD is very difficult to be cured specially #AATD lung disease by $BEAM $WVE $XBI $IBB $MREO its ridiculous that Alvelestat has $0 value despite good results in severe alpha-1 antitrypsin deficiency. #AATD [--] randomized controlled phase [--] trials [---] patients. -Favorable safety profile -good efficacy $WVE $Beam $prme $NTLA $XBI $MREO its ridiculous that Alvelestat has $0 value despite good results in severe alpha-1 antitrypsin deficiency. #AATD 2"
X Link @ej23ny 2026-01-30T17:35Z [----] followers, [----] engagements

"$azn investing in #china not helping no (good) news no party #biotechs $XBI $IBB $BBC no (good) news no party #biotechs $XBI $IBB $BBC"
X Link @LTbioinvestor 2026-01-30T16:09Z 17.2K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

$ibb
/topic/$ibb